Comparison of the Effects of Target-Controlled Infusion Method and Manual Propofol Administration on Respiratory Function, Recovery, and Electroencephalogram in Endoscopic Submucosal Dissection Cases
NCT07305857 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2025-12-26
Summary
Endoscopic submucosal dissection (ESD) has become widely used as a minimally invasive alternative for the resection of early-stage gastrointestinal neoplasms. Due to the lengthy procedure time and intense pain caused by stretching, cutting, and dissecting the gastric wall during ESD, a deeper level of sedation is recommended compared to traditional endoscopic procedures (1). While ensuring adequate patient immobilisation during ESD, preserving respiratory function and rapid recovery are important clinical goals.
Total intravenous anaesthesia (TIVA) is an alternative method to inhalation anaesthesia, achieved through the combination of agents such as propofol and remifentanil. TIVA applications can be performed using manual or target-controlled infusion (TCI) systems. TCI systems aim to achieve and maintain the targeted plasma or effect site concentration based on pharmacokinetic models. These systems have been shown to provide advantages such as more stable depth of sedation during endoscopy, less haemodynamic fluctuation, and faster recovery (2-4).
Preserving spontaneous breathing is preferred during ESD procedures, which requires careful monitoring of respiration. The Capnostream® device records four variables (SpO₂, RR, non-invasive EtCO₂, heart rate) every 30 seconds via a nasal cannula and integrates them into a single, dimensionless value called the integrated pulmonary index (IPI). The IPI can range from 1 to 10, with 4 and below requiring intervention and 8 to 10 representing the normal range. Furthermore, the use of the bispectral index (BIS) enables objective monitoring of anaesthesia depth by analysing EEG waves and can increase the safety of the recovery process (5).
This study aims to compare the effects of manual TIVA and TCI applications on recovery time, BIS, and respiratory parameters during ESD procedures in the stomach or colon region performed under sedation in the endoscopy unit. The findings will contribute to the safer and more effective planning of sedation applications.
References;
1. Sasaki T, Tanabe S, Azuma M, Sato A, Naruke A, Ishido K, et al. Propofol sedation with bispectral index monitoring is useful for endoscopic submucosal dissection: a randomised prospective phase II clinical trial. Endoscopy. 2012 Jun;44(6):584-9.
2. Chang YT, Tsai TC, Hsu H, Chen YM, Chi KP, Peng SY. Sedation for gastrointestinal endoscopy with the application of target-controlled infusion. Turk J Gastroenterol Off J Turk Soc Gastroenterol. 2015 Sep;26(5):417-22.
3. Sarraj R, Theiler L, Vakilzadeh N, Krupka N, Wiest R. Propofol sedation in routine endoscopy: A case series comparing target controlled infusion vs manually controlled bolus concept. World J Gastrointest Endosc. 2024 Jan 16;16(1):11-7.
4. García Guzzo ME, Fernandez MS, Sanchez Novas D, Salgado SS, Terrasa SA, Domenech G, et al. Deep sedation using propofol target-controlled infusion for gastrointestinal endoscopic procedures: a retrospective cohort study. BMC Anaesthesiol. 10 August 2020;20(1):195.
5. Sandler NA, Hodges J, Sabino M. Assessment of recovery in patients undergoing intravenous conscious sedation using bispectral analysis. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg. 2001 Jun;59(6):603-11; discussion 611-612.
6. Ding Y, White PF. Simplified quality of anaesthesia scoring system. Anaesthesia. 1992 Oct;47(10):906-7.
Conditions
- Endoscopic Submucosal Dissection
- Target Controlled Infusion of Propofol
- Endoscopy Unit
- Respiratory Complications
Interventions
- PROCEDURE
-
manuel propofol and target controlled infusion propofol
This study aims to compare the effects of manual TIVA and TCI propofol administration on recovery time, BIS, and respiratory parameters during ESD procedures performed in the endoscopy unit under sedation in the stomach or colon region. The findings will contribute to the safer and more effective planning of sedation procedures.
Sponsors & Collaborators
-
Marmara University Pendik Training and Research Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-01-01
- Primary Completion
- 2027-01-01
- Completion
- 2027-03-01
More Related Trials
-
Endoscopic Submucosal Dissection (ESD) and Endoscopic Mucosal Band Ligation (EMBL) for Early Cancer
NCT02952794 ·Status: UNKNOWN
-
Learning Curve for Gastric Endoscopic Submucosal Dissection
NCT05265221 ·Status: COMPLETED
-
Pain After Endoscopic Submucosal Dissection
NCT02254889 ·Status: COMPLETED ·Phase: NA
-
The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study
NCT02235246 ·Status: COMPLETED ·Phase: PHASE4
-
Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer
NCT03857737 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Use of Lidocaine in Endoscopic Submucosal Dissection
NCT02543411 ·Status: COMPLETED ·Phase: NA
-
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity
NCT04500392 ·Status: RECRUITING ·Phase: NA
-
A Clinical Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Capsules for Preoperative Preparation in Painless Gastrointestinal Endoscopy Procedures
NCT07271303 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer
NCT01943253 ·Status: COMPLETED ·Phase: NA
-
Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm)
NCT03082079 ·Status: UNKNOWN ·Phase: NA
-
Magnetic Guided Counetrtraction During Endoscopic Submucosal Dissection
NCT06962293 ·Status: RECRUITING ·Phase: NA
-
Effect of Midazolam Premedication on the Satisfaction Levels of Patients After Endoscopic Submucosal Dissection
NCT02504164 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Hemostatic Powder in Preventing Bleeding After Gastric Endoscopic Submucosal Dissection in High-risk Patients: A Prospective Randomized Control Study
NCT03169569 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection
NCT01157598 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Using Regular or Rotary Polypectomy Snare for the Resection of Colorectal Polyps
NCT03608930 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort Study on the Safety and Efficacy of Endorobotics for Endoscopic Submucosal Dissection (Endorobotics ESD)
NCT06726798 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study on the Safety and Effectiveness of Endoscopic Intracavitary Submucosal Dissection for Gastric Extracavitary-Type Submucosal Tumors
NCT07337980 ·Status: NOT_YET_RECRUITING
-
Endoscopic Hand Suturing in the Prevention of Gastrointestinal Bleeding After Gastric Endoscopic Submucosal Dissection.
NCT06779266 ·Status: COMPLETED
-
Endoscopic Closure of Gastric ESD Defect
NCT04282707 ·Status: UNKNOWN ·Phase: NA
-
Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients
NCT07252102 ·Status: RECRUITING ·Phase: NA
-
This Randomized, Single-center Trial Aims to Evaluate the Advantages of Underwater ESD (U-ESD) in Comparison to the Conventional ESD (C-ESD).
NCT07040020 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Submucosal Dissection vs. Transanal Endoscopic Surgery for Rectal Neoplasia
NCT06902701 ·Status: NOT_YET_RECRUITING
-
Prediction Model of Hypoxemia in Gastrointestinal Endoscopy Sedation
NCT06016998 ·Status: COMPLETED
-
Role of Hemostatic Powder (Endo-clotTM) in Prevention of Bleeding Within High Risk Patients After ESD
NCT02625792 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Rectal Endoscopic Submucosal Dissection to Endoscopic Mucosal Resection
NCT02198729 ·Status: COMPLETED ·Phase: NA